Notable Nobels
Activesciencelife

Notable Nobels

by Harrison Dulin

Is this your podcast?

Insights from recent episode analysis

Audience Interest

Estimated Reach: 15K to 60K
Listeners across platforms

Podcast Focus

Categories: science · life

Publishing Consistency

Frequency: ~Weekly
29 episodes since 2020

Platform Reach

Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.

Medium Confidence

Total monthly reach

15K to 60K

Estimated from 2 chart positions in 2 markets.

By chart position

  • 🇺🇸
    US · Life Sciences
    #138
    5K to 30K
  • 🇮🇸
    IS · Life Sciences
    #44
    10K to 30K
  • Per-Episode Audience

    Est. listeners per new episode within ~30 days

    7.5K to 30K
    🎙 Weekly cadence·29 episodes·Last published 3mo ago
  • Monthly Reach

    Unique listeners across all episodes (30 days)

    15K to 60K
    🇺🇸50%🇮🇸50%
  • Active Followers

    Loyal subscribers who consistently listen

    4.5K to 18K

Market Insights

This ShowCategory Avg
No category insights available.
📡

Platform Distribution

Reach across major podcast platforms, updated hourly

Total Followers

Total Plays

Total Reviews

YouTube

YouTube

Subscribers

Views

Videos

Castbox

Castbox

Followers

Plays

Reviews

Podcast App

Podcast App

Followers

Plays

Reviews

Podcast Republic

Podcast Republic

Followers

Plays

Reviews

TuneIn

TuneIn

Followers

Plays

Reviews

* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.

On the show

Recent episodes

Episode 28: Phagocytosis and Innate Immunity 1908a

Feb 16, 2026

23m 00s

Special Episode: What is the Nobel Prize?

Oct 17, 2025

51m 58s

Episode 27: Prions Part II 1997

Jun 18, 2025

31m 14s

Episode 26: Prions Part I 1976b

Mar 4, 2025

28m 39s

Episode 25: Rational Design of Antiviral Drugs 1988a

Dec 1, 2024

26m 51s

🔗

Social Links & Contact

Official channels & resources

🌐

Official Website

Login

📡

RSS Feed

Login

Chart Positions

2 placements across 2 markets.